article thumbnail

Good news for FQHCs and Look-Alikes: HRSA will issue the first New Access Points (NAP) NOFO in years on Dec. 12!

Seliger + Associates Grant Writing

I have no idea why HRSA has not issued any NAP NOFOs for years, but, if your organization is an FQHC, LookAlike, or wants to become an FQHC, I’d get on this NAP NOFO bus—who knows when the next NAP NOFO bus will come along. We’re tanned, fit and ready to rock ‘n roll.

HRSA 40
article thumbnail

Standing Up A New Grants Management Function

The NonProfit Times

To get started: Before applying for grants, assess your organization’s level of grant readiness. Grant readiness is your organization’s ability to apply for, manage and report on funding. For instance, I searched, “HRSA Uniform Guidance” and found a web page outlining how the agency interprets the UG, including tip sheets.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Standing Up a New Grants Management Function

Grant Professionals Association

To get started: Before applying for grants, assess your organization’s level of grant readiness. Grant readiness is your organization’s ability to apply for, manage and report on funding. For instance, I searched, “HRSA Uniform Guidance” and found a web page outlining how the agency interprets the UG, including tip sheets.

article thumbnail

Essential Funding Opportunities: Maximize Your Chances for Financial Support

Allied Grant Writers

Health Resources and Services Administration (HRSA) Grants : Nonprofits focused on healthcare can benefit from HRSA’s numerous funding programs, which focus on improving access to quality healthcare services in underserved communities. Ready to secure your funding for 2025?

Funding 52
article thumbnail

The end of SAMHSA’s “waivered prescriber” MAT requirement: a grant writer’s farewell

Seliger + Associates Grant Writing

”* Until this year, the Drug Enforcement Agency (DEA) required that doctors and nurse practitioners (NPs) / physicians assistants (PAs) who prescribe buprenorphine—the key medication used to treat persons with what SAMHSA and HRSA like to call “opioid use disorder” (OUD)—get a special DEA waiver.

SAMHSA 40